Hospital
Mainehealth
Mainehealth was paid $1.64M by Medicaid between Jan 2018 and Feb 2020, across 67 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 76% of everything it billed.
33Billing provider infoMAINEHEALTH
PORTLAND, ME 04101
PORTLAND, ME 04101
33aNPI1346267879assigned 07/17/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.64M
24GClaims47,240
24DCodes billed67
24AFirst – last monthJan 2018 – Feb 2020
Compared with peers
Next to other General Acute Care Hospital providers in Maine
Rank by total paid#22 of 33
Median peer was paid$4.34M
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official INZANA, LUGENE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,652 | $741K | |
| 2019 | 22,688 | $762K | |
| 2020 | 2,900 | $137K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 76% | 19,745 | 15,596 | $1.24M |
| G0008 | Administration of influenza virus vaccine | 3.0% | 2,002 | 1,975 | $49K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.7% | 778 | 726 | $44K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.4% | 2,125 | 2,030 | $40K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.2% | 612 | 609 | $35K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.7% | 492 | 490 | $28K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.7% | 1,742 | 927 | $28K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 1.6% | 389 | 324 | $26K |
| G0009 | Administration of pneumococcal vaccine | 1.2% | 796 | 785 | $19K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.0% | 1,299 | 616 | $17K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.0% | 384 | 350 | $16K |
| 90686 | <1% | 1,791 | 1,769 | $13K |
55 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 257 | $12K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 153 | $11K |
| 90670 | <1% | 629 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 302 | $6K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 294 | $6K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 295 | $6K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 97 | $6K |
| 90732 | <1% | 139 | $6K | |
| 80061 | Lipid panel | <1% | 514 | $4K |
| 90651 | <1% | 79 | $2K | |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 128 | $2K |
| 97161 | <1% | 82 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 535 | $1K |
| 80305 | <1% | 933 | $1K | |
| 80053 | Comprehensive metabolic panel | <1% | 808 | $1K |
| 97014 | <1% | 66 | $1K | |
| 96127 | <1% | 114 | $901.71 | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 16 | $862.58 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 662 | $707.24 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 510 | $634.80 |
| D1206 | Topical application of fluoride varnish | <1% | 50 | $588.00 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 70 | $560.86 |
| 98925 | <1% | 422 | $537.50 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,452 | $396.67 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 283 | $373.60 |
| 90662 | <1% | 112 | $366.74 | |
| 88142 | <1% | 61 | $363.78 | |
| 81025 | <1% | 337 | $250.33 | |
| 98926 | <1% | 303 | $154.53 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 340 | $147.00 |
| 85610 | <1% | 313 | $136.22 | |
| 86803 | <1% | 52 | $104.42 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 28 | $88.20 |
| 98927 | <1% | 31 | $64.91 | |
| 90715 | <1% | 563 | $44.00 | |
| 90744 | <1% | 219 | $31.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 28 | $23.42 |
| 81002 | <1% | 561 | $15.72 | |
| 82043 | <1% | 26 | $10.44 | |
| 87070 | <1% | 46 | $8.80 | |
| 85027 | <1% | 18 | $6.62 | |
| 81001 | <1% | 14 | $3.24 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 31 | $0.00 |
| 83037 | 0% | 544 | $0.00 | |
| 90633 | 0% | 147 | $0.00 | |
| 90707 | 0% | 30 | $0.00 | |
| 90700 | 0% | 12 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 743 | $0.00 |
| 90685 | 0% | 57 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 109 | $0.00 |
| 90681 | 0% | 84 | $0.00 | |
| 36416 | 0% | 845 | $0.00 | |
| 90698 | 0% | 379 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 82 | $0.00 |
| 90474 | 0% | 80 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialINZANA, LUGENE (ASSOCIATE CFO)
| Provider | Location | Paid |
|---|---|---|
| Mainehealth | Portland, ME | $142.72M |
| Mainehealth | Portland, ME | $115.05M |
| Mainehealth | Biddeford, ME | $70.83M |
| Mainehealth | Brunswick, ME | $40.06M |
| Mainehealth | Farmington, ME | $22.62M |
| Mainehealth | Biddeford, ME | $10.89M |
| Mainehealth | Falmouth, ME | $6.54M |
| Mainehealth | Portland, ME | $5.46M |
| Mainehealth | Scarborough, ME | $5.04M |
| Mainehealth | Rockport, ME | $4.34M |
| Mainehealth | Scarborough, ME | $4.16M |
| Mainehealth | Portland, ME | $4.09M |
| Mainehealth | Scarborough, ME | $3.94M |
| Mainehealth | Portland, ME | $3.55M |
| Mainehealth | Waldoboro, ME | $3.43M |
| Mainehealth | Scarborough, ME | $3.18M |
| Mainehealth | Brunswick, ME | $2.77M |
| Mainehealth | Portland, ME | $2.68M |
| Mainehealth | Falmouth, ME | $2.10M |
| Mainehealth | Portland, ME | $1.87M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.